Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis.
BMC Cancer. 2023 Nov 6;23(1):1066. doi: 10.1186/s12885-023-11572-0.
BMC Cancer. 2023.
PMID: 37932689
Free PMC article.
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Wang R, Gao D, Chen C, Fan G, Cheng H, Tao Y, Lu J, Tian J, Wang Y, Wang Z.
Wang R, et al.
Clin Transl Oncol. 2023 May;25(5):1425-1435. doi: 10.1007/s12094-022-03044-x. Epub 2022 Dec 13.
Clin Transl Oncol. 2023.
PMID: 36512304
Item in Clipboard
Cite
Cite